…
The Calmer Co International Limited operates as a health and wellness company in Australia, Fiji, New Zealand, the United States, and internationally. It operates through four segments: Fiji Kava Trading, SPE Fiji, Fiji Kava USA, and Danodan. It produces and sells powdered drinking kava, teas, and capsules under the FijiKava brand name; flavoured and non-flavoured kava shots, tinctures, and traditional and instant drinking kava under the Taki Mai brand name; hemp, CBD oils, topical salves, and pet CBD oils under Danodan brand name. In addition, it sells its products through retailers and online. The company was formerly known as Fiji Kava Limited and changed its name to The Calmer Co International Limited in April 2023. The Calmer Co International Limited was incorporated in 2014 and is based in Yeronga, Australia.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on The Calmer Co International Ltd (ASX: CCO) is limited; available disclosures indicate it is a consumer wellness company selling branded wellbeing products. Long-term growth drivers that could support the business include rising consumer focus on mental health, expansion of e-commerce and international distribution, and product innovation, which may make it attractive if it can scale brand and distribution.
Key investment risks include limited financial disclosure and small scale that heighten execution and financing risk, intense competition in consumer wellness, and regulatory developments that could materially affect revenue.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Income before tax | -3.81M | -3.99M | -3.73M | -5.24M | -5.46M |
| Net income | -3.81M | -3.99M | -3.73M | -5.24M | -5.46M |
| Selling general administrative | - | 0.64M | 2.17M | 1.97M | 2.09M |
| Selling and marketing expenses | - | 2.53M | 1.22M | 0.87M | 2.07M |
| Gross profit | 0.83M | 3.48M | 2.05M | -1.40M | 0.67M |
| Reconciled depreciation | - | - | 0.20M | - | - |
| Ebit | -3.39M | -3.57M | -3.54M | -4.30M | -5.42M |
| Ebitda | -3.00M | -3.45M | -3.34M | -4.07M | -5.28M |
| Depreciation and amortization | 0.39M | 0.12M | 0.20M | 0.23M | 0.15M |
| Operating income | -3.39M | -2.20M | -1.88M | -4.30M | -5.42M |
| Other operating expenses | 11.51M | 10.23M | 6.15M | 6.08M | 7.50M |
| Interest expense | 0.37M | 0.20M | 0.17M | 0.26M | 0.04M |
| Tax provision | - | 0.00M | 0.00M | 0.00M | 0.00M |
| Interest income | - | 0.23M | 0.00M | 0.26M | 0.05M |
| Net interest income | - | - | -0.17M | - | - |
| Income tax expense | - | - | -0.00M | -0.00M | 0.03M |
| Total revenue | 8.12M | 8.03M | 4.26M | 1.78M | 2.08M |
| Total operating expenses | 4.22M | 5.68M | 3.93M | 2.89M | 6.08M |
| Cost of revenue | 7.29M | 4.55M | 2.21M | 3.19M | 1.42M |
| Total other income expense net | -0.42M | -1.80M | -1.84M | -0.94M | -0.01M |
| Net income from continuing ops | - | - | -3.73M | - | - |
| Net income applicable to common shares | - | -3.99M | -3.73M | -5.24M | -5.92M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Total assets | 4.91M | 5.68M | 4.33M | 3.24M | 4.79M |
| Intangible assets | 0.36M | 0.42M | - | 0.47M | 0.88M |
| Other current assets | 0.21M | 0.64M | 0.09M | - | 0.52M |
| Total liab | 5.36M | 3.78M | 4.80M | 3.32M | 2.51M |
| Total stockholder equity | -0.45M | 1.90M | -0.47M | -0.09M | 2.28M |
| Other current liab | 0.63M | 0.73M | 0.76M | - | 0.97M |
| Common stock | 36.46M | 34.97M | 28.77M | 25.39M | 22.30M |
| Retained earnings | -37.19M | -33.38M | -29.39M | -25.48M | -19.86M |
| Good will | - | - | - | - | 0.33M |
| Cash | 0.67M | 1.46M | 1.07M | - | 0.80M |
| Cash and equivalents | - | - | - | 0.46M | 0.81M |
| Total current liabilities | 4.13M | 2.10M | 3.25M | 2.43M | 0.97M |
| Current deferred revenue | 0.01M | - | 0.69M | - | 0.02M |
| Net debt | 3.21M | 0.85M | 1.15M | - | 0.28M |
| Short term debt | 2.68M | 0.64M | 0.67M | 0.22M | 0.14M |
| Short long term debt total | 3.88M | 2.31M | 2.21M | - | 1.08M |
| Other stockholder equity | - | - | - | - | -0.67M |
| Property plant equipment | - | - | - | 0.96M | 0.91M |
| Total current assets | 2.98M | 4.12M | 3.08M | 1.81M | 2.99M |
| Short term investments | - | 0.03M | 0.03M | - | - |
| Net receivables | 0.76M | 0.47M | 0.64M | 0.30M | 0.21M |
| Long term debt | - | - | - | 0.89M | 1.53M |
| Inventory | 1.34M | 1.56M | 1.25M | 0.88M | 1.49M |
| Accounts payable | 0.81M | 0.73M | 1.12M | - | 0.33M |
| Accumulated other comprehensive income | 0.28M | 0.32M | 0.16M | - | 0.51M |
| Non currrent assets other | - | - | 0.47M | - | -0.00M |
| Non current assets total | 1.93M | 1.56M | 1.26M | - | 1.79M |
| Long term debt total | - | - | - | 0.89M | 1.53M |
| Breakdown | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
| Investments | - | - | -0.12M | - | - |
| Total cashflows from investing activities | -0.05M | -0.46M | -0.12M | -0.02M | -0.97M |
| Total cash from financing activities | 2.19M | 5.19M | 2.83M | 3.47M | 6.03M |
| Net income | -3.81M | -3.99M | -3.73M | -5.24M | -5.92M |
| Change in cash | -0.76M | 0.36M | 0.64M | -0.35M | -0.38M |
| Begin period cash flow | 1.43M | 1.10M | 0.46M | 0.78M | 1.18M |
| End period cash flow | 0.67M | 1.46M | 1.10M | 0.43M | 0.80M |
| Total cash from operating activities | -2.94M | -4.37M | -2.08M | -3.80M | -6.14M |
| Issuance of capital stock | - | - | 2.27M | - | - |
| Depreciation | 0.39M | 0.28M | 0.20M | 0.23M | 0.15M |
| Other cashflows from investing activities | - | - | -0.05M | - | - |
| Change to inventory | 0.21M | -0.30M | -0.37M | 0.60M | -1.46M |
| Change to account receivables | -0.16M | -0.38M | -0.26M | 0.24M | 0.74M |
| Sale purchase of stock | - | 5.27M | 2.27M | 3.09M | 5.24M |
| Other cashflows from financing activities | -0.20M | - | -0.04M | 0.83M | 2.31M |
| Capital expenditures | 0.05M | 0.46M | 0.12M | 0.02M | 0.96M |
| Change in working capital | 0.45M | -0.67M | 1.17M | 1.19M | -0.42M |
| Stock based compensation | - | 0.28M | 0.12M | 0.07M | - |
| Other non cash items | 0.03M | -0.27M | 0.17M | -0.40M | 0.05M |
| Free cash flow | -2.98M | -4.83M | -2.19M | -3.82M | -7.10M |
Sector: Consumer Defensive Industry: Packaged Foods
|
Stock Name
|
Change
(AUD) |
Price
(AUD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CCO The Calmer Co International Ltd |
- -% |
0.00 | - | - | 0.66 | 28.50 | 1.05 | -0.54 |
| A2M The a2 Milk Company Ltd |
-0.07 0.96% |
7.19 | 29.04 | 28.74 | 2.68 | 5.94 | 2.85 | 17.82 |
| BGA Bega Cheese Ltd |
-0.02 0.30% |
6.74 | 35.61 | 22.94 | 0.52 | 1.93 | 0.60 | 11.82 |
| CBO Cobram Estate Olives Ltd |
-0.06 2.26% |
2.59 | - | - | 4.79 | 2.48 | 6.63 | 185.44 |
| RIC Ridley Corporation Ltd |
0.02 0.74% |
2.74 | 38.29 | 13.42 | 0.35 | 2.01 | 0.53 | 4.50 |
The Calmer Co International Limited operates as a health and wellness company in Australia, Fiji, New Zealand, the United States, and internationally. It operates through four segments: Fiji Kava Trading, SPE Fiji, Fiji Kava USA, and Danodan. It produces and sells powdered drinking kava, teas, and capsules under the FijiKava brand name; flavoured and non-flavoured kava shots, tinctures, and traditional and instant drinking kava under the Taki Mai brand name; hemp, CBD oils, topical salves, and pet CBD oils under Danodan brand name. In addition, it sells its products through retailers and online. The company was formerly known as Fiji Kava Limited and changed its name to The Calmer Co International Limited in April 2023. The Calmer Co International Limited was incorporated in 2014 and is based in Yeronga, Australia.
| Name | Title | Year Born |
|---|---|---|
| Dr. Anthony Noble | MD, CEO & Director | NA |
| Mr. Zane Yoshida B.Tech., M.B.A. | Founder, COO & Executive Director | NA |
| Dr. Anthony Noble | MD, CEO & Director | NA |
| Mr. Zane Yoshida B.Tech., M.B.A. | Founder, COO & Executive Director | NA |
| Ms. Sharmila Nanayakkara | Chief Financial Officer | NA |
| Prof. Jerome Sarris | Member Scientific Advisory Board & Chief Scientist | NA |
| Mr. Brian Casutto | Managing Director of FijiKava Inc (USA) | 1971 |
| Ms. Natalie Climo | Company Secretary | NA |
| Dr. Anthony Noble | MD, CEO & Director | NA |
| Mr. Zane Yoshida B.Tech., M.B.A. | Founder, COO & Executive Director | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.